| Name | Title | Contact Details |
|---|
InterVene`s mission is to provide the first effective and widely-utilized therapy for patients suffering from the painful and costly symptoms of Chronic Venous Insufficiency (CVI) due to deep vein reflux (DVR).
Amekam International is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HeartFlow is a medical technology company transforming the way cardiovascular disease is diagnosed and treated. With our HeartFlow Analysis, a non-invasive personalized cardiac test, physicians are able to make better care decisions for their patients with suspected coronary artery disease--the number one killer of men and women worldwide. HeartFlow is backed by decades of scientific research and development and leverages the latest advancements in technology to help set a new standard of care for diagnosing cardiovascular care worldwide. Cleared for use in the United States, Canada, Europe and Japan and with offices in Redwood City, Austin, London and Japan, HeartFlow`s footprint is growing rapidly. HeartFlow has received more than $240 million dollars in funding in a recent Series E financing round, is pre-IPO and leverages the latest technology including deep learning and computational fluid dynamics. We try to embody the best of both technology and healthcare companies and hire people who are passionate about living our mission to save lives, improve the patient experience and reduce the overall cost of care.
Infab Corporation is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Merit Medical Systems, Inc is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures. Its primary products consist of inflation devices used in angioplasty, stent placement and discography; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; guide wires used to place balloon angioplasty catheters within a patient`s coronary arteries; products used to manage and monitor the administration of contrast and other fluid solutions during diagnostic and therapeutic procedures; thrombolytic catheters and fluid dispensing systems; angiography accessories; and standard and custom angiography kits. Headquartered in South Jordan, Utah, a suburb of Salt Lake City, Merit employs approximately 1,900 people worldwide. Merit markets its products in the United States and Europe (direct sales force) and the world (distributors). They call directly on physicians and clinicians in hospitals and clinics worldwide. The Company has expanded to three separate facilities in the Salt Lake City, Utah area (South Jordan, Murray and West Jordan). Merit also has facilities in Galway, Ireland (guidewires), Angleton, Texas (catheters), in Richmond, Virginia (procedural trays and packs) and a customer service and distribution center in Maastricht, The Netherlands. The Company has achieved a world leadership position in inflation devices and hemostasis valves and is renowned for its product innovation, customer service and product quality. Merit possesses a proprietary manufacturing process which allows it to offer contract manufacturing (OEM) to a wide range of medical device companies. Merit Endotek is a newly created division of Merit. These products are focused in the gastroenterology medical device market. The products include stent technology in the emerging field of non-vascular interventional stenting. This next-generation stent technology is used in the lungs, esophagus, and biliary tract.